Have only started to follow GWR recently and have been weighing up buying in but the free fall in share price has kept me out. Feel free to comment or correct any errors in the following:
FAS $1.5M cash and 98M shares on issue at 31 Dec 07 (1.5c/share cash backing)
GWR $32M? cash and 110M shares on issue based on recent announcement. (29c/share cash backing)
If the takeover succeeded then existing FAS shareholders retain approx 11% (98M out of 868M shares) of united entity that has $33.5M cash. So far I see no upside for GWR holders as they are just diluting their cash backing.
Then if you look at the supposed mining assets that each has, with GWR seemingly sitting on a massive resource and FAS seeming to not have much at all, I am failing to see the value gain in accepting the takeover offer.
So a change in management is the only possible story for GWR shareholders and one wonders how much GWR shareholders are prepared to pay for a change without any form of guarantee that they are getting a better operator.
- Forums
- ASX - By Stock
- GWR
- convince my mate to hold onto his gwr shares
convince my mate to hold onto his gwr shares, page-9
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GWR (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18178 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 120611 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18178 | 0.084 |
2 | 139548 | 0.083 |
1 | 12195 | 0.082 |
1 | 190000 | 0.081 |
3 | 372500 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 120611 | 2 |
0.087 | 98397 | 1 |
0.088 | 50006 | 1 |
0.090 | 50431 | 1 |
0.092 | 123633 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
GWR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online